Clinical Trials Logo

Fractures, Bone clinical trials

View clinical trials related to Fractures, Bone.

Filter by:

NCT ID: NCT01752452 Completed - Clinical trials for Fracture of Distal End of Radius

Effect of Ulnar Styloid Fracture on the Outcome of Distal Radial Fractures Treated With External Fixation

Start date: January 2009
Phase: N/A
Study type: Observational [Patient Registry]

Untreated ulnar styloid fracture may affect the outcomes of distal radial fracture patient treated with external fixation.

NCT ID: NCT01741168 Completed - Clinical trials for Thoracolumbar Burst Fractures Without Neurologic Deficit

Brace Versus No Brace for the Treatment of Thoracolumbar Burst Fractures Without Neurologic Injury

Start date: June 2005
Phase: N/A
Study type: Interventional

Braces have been used o treat stable (not requiring surgery) burst fractures with much success. Recently questions have been raised in regards to the importance of the brace. Some studies have results that suggest a brace is not important in having a good outcome. However, this has never been proven. This study is being conducted to see whether or not wearing a brace is important to having a good outcome.

NCT ID: NCT01738776 Completed - Hip Fracture Clinical Trials

Nutritional Risk Factors for Hip Fracture: a Case Control Study

Start date: September 2009
Phase: N/A
Study type: Observational

Low Body Mass Index (BMI) is a risk factor for hip fracture, but it is unknown if it is the low BMI per se that increases risk of hip fracture or if specific micro-nutrients contribute. The investigators want to elucidate this aspect in a case control study studying micronutrients in serum and bone turnover markers of hip fracture patients compared with controls of the same age.

NCT ID: NCT01737385 Completed - Clinical trials for Proximal Humeral Fractures

Examination of Microcirculation of the Caput Humeri After Proximal Humerus Fracture

Start date: May 2012
Phase: N/A
Study type: Observational

This study examines the microcirculation of the caput humeri after proximal humeral fracturation using O2C light probes. During the operation the blood circulation is measured at four points (tuberculum majus, tuberculum minus, neck and head of the humerus) directly on the bone. The O2C light probes are a none-invasive technique of measuring blood flow, velocity and oxygen concentration. The data is analysed in respect to the fracture type according to the classification of Neer. Valuable additional information for the correct treatment and prognosis of humeral fractures is expected.

NCT ID: NCT01737060 Completed - Clinical trials for Proximal Humeral Fractures, AO/OTA (2007) Group B2 and C2

Displaced Proximal Humeral Fractures: Delta Prothesis or Philos Plate?

DELPHI
Start date: January 1, 2013
Phase: N/A
Study type: Interventional

To investigate the assumption that reversed shoulder prosthetic replacement will give a better functional outcome compared to open reduction and internal fixation with an angular stable plate in displaced proximal humeral fractures. Short name: The DelPhi trial.

NCT ID: NCT01714336 Completed - Hip Fracture Clinical Trials

Does Tranexamic Acid Reduce the Need for Blood Transfusions in Patients Undergoing Hip Fracture Surgery?

Start date: September 2012
Phase: Phase 4
Study type: Interventional

Does tranexamic acid improve the perioperative care of those patients treated surgically for hip fracture by decreasing the proportion of patients requiring transfusion and decreasing total perioperative bleeding.

NCT ID: NCT01705587 Completed - Osteoporosis Clinical Trials

Fracture (FX) Improvement With Teriparatide: FiX-IT Study

FiX-IT
Start date: December 2012
Phase: Phase 4
Study type: Interventional

This open label comparison study examines the hypothesis that teriparatide given immediately following repair of an atypical subtrochanteric or diaphyseal femoral shaft fracture will enhance healing and improve bone mineral density compared to delayed treatment (after six months) with teriparatide or no treatment with teriparatide (patients who refuse therapy or for whom teriparatide is contraindicated). Patients with up-front teriparatide in addition will have greater quality of life measures and less pain compared to those with delayed or no therapy.

NCT ID: NCT01701414 Completed - Hip Fractures Clinical Trials

Ultrasound-guided Femoral Nerve Blocks in Elderly Patients With Hip Fractures

FNB
Start date: November 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine if ultrasound guided femoral nerve blocks (localized anesthesia in the upper thigh) provide effective pain relief in adult patients with hip fractures in the emergency department and to determine if femoral nerve blocks can then be used to reduce the use of injected analgesia (anesthesia), therefore also causing fewer adverse effects associated with injected analgesia (such as bruising at the site of injection). 100 patients with hip fractures will be enrolled in the study. Patients will be randomly assigned to receive a femoral nerve block (FNB) plus injected analgesia or standard care (SC), which is injected analgesia alone. Using guidance from an ultrasound machine, the FNB group will have 20ml of 0.5% bupivacaine (a local anesthetic of long duration) injected into the front of the thigh, at the site of pain. Patients randomized to the SC group will receive an injection of saline (saltwater) so that no neither the patient or the treating physician knows to which group the patient was randomized. All blocks will be performed in the emergency department by an emergency physician trained in the use of ultrasound and ultrasound guided nerve blocks. Subjects will be asked to rate their pain on a numeric pain scale both before and after intervention (30 min, 60 min, 12 hrs and 24 hrs after injection, as long as the patient is in the ER still). Additional data to be collected includes demographics, vital signs, and course of treatment resulting from the ED visit. Hypothesis: US-guided femoral nerve blocks can provide effective pain control and possibly decrease or eliminate the need for narcotics.

NCT ID: NCT01698463 Completed - Clinical trials for Fall and Fractures Prevention

Prescribe Exercise for Prevention of Falls and Fractures: A Family Health Team Approach

PEPTEAM
Start date: January 2012
Phase: N/A
Study type: Interventional

Falls and fractures are a leading cause of death and disability in the older adult population. The consequences of falls and fractures contribute substantially to health care costs and can have a significant negative impact on the quality of life of the individual. Exercise has been studied as an option to reduce fracture risk and prevent falls though improving balance and muscle strength. The prevention of falls is important, as a history of falls is strongly predictive of suffering another. Those who are at a high risk of fracture or falling require a patient specific assessment and individualized exercise prescription that is tailored to their needs. This kind of program may not be typically available within the community and at a low cost. These individuals may experience difficulty when trying to engage in exercise due to barriers such as a lack of transportation, and a lack of knowledge. As the first point of contact with the health care system for many family doctors are in the ideal position to deliver exercise advice to their patients. However, a lack of time and specialized skills in prescribing exercise make this difficult for many of them. As a result, family health teams who provide interdisciplinary patient centered care are becoming popular. In this model the care is shared and provided by the most appropriate team member (e.g. doctor, nurse, exercise specialist). Additionally, many exercise interventions do not include a behavior change aspect, which may be an important component when trying to get individuals to engage in a new health behavior like exercise. Therefore the purpose of this project is to assess the feasibility of implementing a tailored exercise program to those at high risk of falls or fractures over the age of 65 in a primary care setting using an interdisciplinary model of care that is based on a health behaviour change model.

NCT ID: NCT01691599 Completed - Tibia Fracture Clinical Trials

Infection Rates Following Internal Fixation of Open and Closed Tibia Fractures in India

Start date: August 2012
Phase:
Study type: Observational

The objectives of this study are to investigate infection rates and management for open and closed tibia fracture subjects in India treated with internal fixation. These objectives will be carried out by answering the following questions: 1. What is the infection rate within one year of surgery for open and closed tibia fracture subjects in India treated with internal fixation? 2. What is the distribution of infection per type of infection, stratified by time (early, delayed, late) and location (superficial or deep) in open and closed tibia fracture subjects in India treated with internal fixation? Secondary objectives 1. How are infections managed in open and closed tibia fracture subjects in India treated with internal fixation? 2. What is the treatment outcome for open and closed tibia fracture subjects in India treated with internal fixation? 3. What is the influence of the following clinic and subject factors on the occurrence of infection within one year for open and closed tibia fracture subjects in India treated with internal fixation? 1. Hospital standard hygienic and antibiotic protocol for infection prevention 2. Subject demographics 3. Time between injury and surgery and between admission and surgery 4. Fracture type (AO Müller classification) 5. Soft tissue damage (according to the Tscherne classification for closed fractures or Gustilo classification for open fractures) 6. Fracture management and implant type 7. Surgical details such as duration of surgery 4. Is there a difference in health-related quality of life as measured by the EuroQol-5 Dimensions (EQ-5D) between subjects with and without infections? 5. Is there a difference in the number of complications not related to infection (adverse events and serious adverse events) between subjects with and without infections?